Dr Mohan Bangalore, senior director and site head, Wyeth India has bagged the Pharmaceutical Executive Magazine (New York) Emerging Leader Award. He is the only Indian to receive the honour this year among 27 others in the field.

The award titled as the Emerging Leaders 2009 is given away to scientists engaged in innovative technologies.

Dr Mohan who received his Ph D in Molecular Biology from Iowa State University (ISU), USA did his post-doctoral training at University of Pennsylvania Medical School, Philadelphia and worked on the biology (latency and reactivation) of Herpes Simplex Virus. He has eight years of academic work experience and nine years of pharmaceutical industry experience in clinical trials, drug development, and clinical research. He worked at GlaxoSmithKline to set up oncology clinical trials in India and China for Tykerb (lapatinib), which is now on the market for treatment of breast cancer.

At Wyeth, he has been responsible for the establishment of the India Clinical Research Center (ICRC) in Bangalore, in association with Accenture. Currently, ICRC has around 160 members supporting core clinical functions like clinical writing, statistical programming, medical research support, document quality, document technology and clinical administrative data support. His task also includes identifying opportunities across functions and develop strategic solutions with stakeholders.